Literature DB >> 7897449

Variable CSF findings in early and late Lyme neuroborreliosis: a follow-up study in 47 patients.

R Kaiser1.   

Abstract

The cerebrospinal fluid (CSF) of 37 patients with early Lyme neuroborreliosis (ELN) and of 10 patients with late Lyme neuroborreliosis (LLN, duration of symptoms > or = 7 months) was investigated for typical features differentiating between acute and chronic courses of disease. Individual patients were studied after 2 and 4 weeks, and 3, 6, and 12 months. Patients with ELN presented predominantly with symptoms of the peripheral nervous system, while patients with LLN generally suffered from symptoms of the central nervous system. At the first lumbar puncture, patients with ELN revealed a more intense pleocytosis in the CSF (P < 0.02) and a higher intrathecal synthesis of total IgM (P < 0.0003) and of Borrelia burgdorferi-specific IgM antibodies (P < 0.01). At the same time, in patients with LLN, the blood-CSF barrier was more severely impaired (P = 0.03), and local production of total IgG (P = 0.0001), of B. burgdorferi-specific IgG antibodies (P = 0.03) and of total IgA (P = 0.001) was more markedly increased. The quantity of intrathecally produced B. burgdorferi-specific IgA antibodies did not differ between the two study groups. Clinical recovery was usually accompanied by a considerable improvement of the blood-CSF barrier function and pleocytosis. After 6 months, the intrathecal synthesis of total IgG had significantly decreased in patients with ELN but not in those with LLN. At the same time, the CSF of most patients in both study groups still contained intrathecally produced B. burgdorferi-specific IgG antibodies. In the absence of clinical illness or symptoms of inflammation 6 and 12 months after treatment, B. burgdorferi-specific IgG antibodies in the CSF might simply indicate an anamnestic reaction to a previous infection of the central nervous system. Six months after antibiotic treatment, patients with ELN still revealed evidence of intrathecal synthesis of total IgM, whereas those with LLN did not. These antibodies, however, were not related to B. burgdorferi.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7897449     DOI: 10.1007/bf00920571

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

1.  Detection of immunoglobulin M antibodies to Treponema pallidum in a modified enzyme-linked immunosorbent assay.

Authors:  F Müller; M Moskophidis; H L Borkhardt
Journal:  Eur J Clin Microbiol       Date:  1987-02       Impact factor: 3.267

2.  Intrathecal synthesis of IgM and IgA in neurological diseases: comparison of two formulae with isoelectric focusing.

Authors:  R Kaiser; C H Lücking
Journal:  Clin Chim Acta       Date:  1993-07-16       Impact factor: 3.786

3.  Detection of Borrelia burgdorferi DNA in urine samples and cerebrospinal fluid samples from patients with early and late Lyme neuroborreliosis by polymerase chain reaction.

Authors:  A M Lebech; K Hansen
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

4.  Immunoglobulin abnormalities in cerebrospinal fluid and blood over the course of lymphocytic meningoradiculitis (Bannwarth's syndrome).

Authors:  A Henriksson; H Link; M Cruz; G Stiernstedt
Journal:  Ann Neurol       Date:  1986-09       Impact factor: 10.422

5.  Demonstration of locally synthesized borrelia antibodies in cerebrospinal fluid.

Authors:  B Rehse-Küpper; R Ackermann
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1987-02

6.  Intrathecal synthesis of specific antibodies in neuroborreliosis. Comparison of different ELISA techniques and calculation methods.

Authors:  R Kaiser; C H Lücking
Journal:  J Neurol Sci       Date:  1993-08       Impact factor: 3.181

7.  Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study.

Authors:  S Hammers-Berggren; K Hansen; A M Lebech; M Karlsson
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

8.  Isolation and cultivation of Lyme disease spirochetes.

Authors:  A G Barbour
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug

9.  SINGLE CELL STUDIES ON 19S ANTIBODY PRODUCTION.

Authors:  G J NOSSAL; A SZENBERG; G L ADA; C M AUSTIN
Journal:  J Exp Med       Date:  1964-03-01       Impact factor: 14.307

10.  Chronic meningitis and Lyme disease in Sweden.

Authors:  G T Stiernstedt; B R Sköldenberg; B Vandvik; B Hederstedt; A Gårde; G Kolmodin; H Jörbäck; B Svenungsson
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug
View more
  22 in total

1.  Serodiagnosis of neuroborreliosis: comparison of reliability of three confirmatory assays.

Authors:  R Kaiser; S Rauer
Journal:  Infection       Date:  1999 May-Jun       Impact factor: 3.553

2.  Internuclear ophthalmoplegia as the first sign of neuroborreliosis.

Authors:  Willem J Hardon; Hans J J A Bernsen; Jose van Nouhuys-Leenders; Bert Mulder
Journal:  J Neurol       Date:  2002-08       Impact factor: 4.849

3.  Mercury exposure as a model for deviation of cytokine responses in experimental Lyme arthritis: HgCl2 treatment decreases T helper cell type 1-like responses and arthritis severity but delays eradication of Borrelia burgdorferi in C3H/HeN mice.

Authors:  C Ekerfelt; M Andersson; A Olausson; S Bergström; P Hultman
Journal:  Clin Exp Immunol       Date:  2007-08-02       Impact factor: 4.330

4.  Cerebrospinal-fluid profile in neuroborreliosis and its diagnostic significance.

Authors:  J Bednárova
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

5.  Lyme Neuroborreliosis.

Authors:  Sebastian Rauer; Stefan Kastenbauer; Volker Fingerle; Klaus-Peter Hunfeld; Hans-Iko Huppertz; Rick Dersch
Journal:  Dtsch Arztebl Int       Date:  2018-11-09       Impact factor: 5.594

Review 6.  [Neuroborreliosis - Diagnostics, treatment and course].

Authors:  R Dersch; S Rauer
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

7.  Intrathecal immune response in patients with neuroborreliosis: specificity of antibodies for neuronal proteins.

Authors:  R Kaiser
Journal:  J Neurol       Date:  1995-05       Impact factor: 4.849

8.  [Clinical courses of acute and chronic neuroborreliosis following treatment with ceftriaxone].

Authors:  R Kaiser
Journal:  Nervenarzt       Date:  2004-06       Impact factor: 1.214

9.  Cytokines in Lyme borreliosis: lack of early tumour necrosis factor-alpha and transforming growth factor-beta1 responses are associated with chronic neuroborreliosis.

Authors:  Mona Widhe; Mattias Grusell; Christina Ekerfelt; Magnus Vrethem; Pia Forsberg; Jan Ernerudh
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

Review 10.  Lyme neuroborreliosis-epidemiology, diagnosis and management.

Authors:  Uwe Koedel; Volker Fingerle; Hans-Walter Pfister
Journal:  Nat Rev Neurol       Date:  2015-07-28       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.